Page 5 - MEMOCiberehd014-ENG

RESEARCH PROGRAMMES AND SCIENTIFIC-TECHNOLOGICAL PLATFORMS
CIBEREHD maintains 6 research programmes, each of which is developed through several major lines of research .
• P1 . Portal hypertension and mechanisms of transition to cirrhosis • P2 . Viral hepatitis • P3 . Hepatotoxicity, cholestasis and disorders metabolic • P4 . Immunology and liver transplantation
• P5 . Hepatic and gastrointestinal oncology • P6 . Gastrointestinal inflammation and motility
CIBEREHD has international opinion leaders in all of these programmes .
Technological Platforms include a Biobank (with two locations, one in Barcelona and one in Valencia), a Transcriptomic, Proteomic, Gene Silencing and Metabolomic Platform (in Vizcaya), a Pyrosequencing Platform, and a Bioinformatic Platform, Platform for Supporting the Diagnosis and Therapeutic Guidance in Liver cancer, Hepatitis B, Hepatitis C and Vascular Hepatic Disease Databases (that depend on Scientific Management) .
This year 490 articles were published in first and second quartile journals, 74 . 8 % (367) of which belong to the first quartile and 44% (216) to the first decile of their specialty . This indicates a continued increase in the quantity and quality of the scientific results of CIBEREHD . Moreover, in 294 publications the main author or the corresponding author belonged to CIBEREHD and 385 of these publications were the produce of a national cooperation and 193 of an international cooperation . Finally, there were 19 publications in high impact journals . The publication of 15 Clinical Guidelines, 9 Clinical trials, the performance of 6 projects with the industry and the licensing of 3 patents stand out among transfer activities .
www.ciberehd.org 5